Wolwo Bio-Pharmaceutical
SZSE · 300357
Market Cap$11.5B
Revenue$1.1B
Employees1808
Listed OnSZSE
Ticker300357
CEO / ExecMr. Guoqi Wang
HeadquartersHuzhou
MarketMainland China
Websitewww.wolwobiotech.com
Overview
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of diagnostic and therapeutic products for allergic diseases in China and internationally. The company offers Changdi, a skin prick test product and dust mite drops; Changhao, an Artemisia annua pollen allergen sublingual drop; and Changdian, a dust mite skin prick test diagnostic kit. It is also involved in the research and development of cells and natural medicines. The company was founded in
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.